Neeltje A. Kootstra

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

Philip J. M. Brouwer, Tom G. Caniels, Karlijn van der Straten et al. · Science · 2020 · 1.3K citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population

Hanneke Schuitemaker, M. Koot, Neeltje A. Kootstra et al. · Journal of Virology · 1992 · 1K citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study

J. Schouten, Ferdinand W.N.M. Wit, Ineke G. Stolte et al. · Clinical Infectious Diseases · 2014 · 774 citations · Full text

Public Health, Geriatric Medicine, Aging +13

Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule

Ron A. M. Fouchier, M Groenink, Neeltje A. Kootstra et al. · Journal of Virology · 1992 · 768 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +13

Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences

Fernando O. Martínez, Laura Helming, Ronny Milde et al. · Blood · 2013 · 494 citations · Full text

Life Sciences, Cell Biology, Immunology +14